Down-regulation of FHIT inhibits apoptosis of colorectal cancer: Mechanism and clinical implication
Authors:
- Jie CaoJCJie Cao
- Wanglin LiWLWanglin Li
- Jie XieJXJie Xie
- Hong DuHDHong Du
- Weibiao TangWTWeibiao Tang
- Hui WangHWHui Wang
- Xiwen ChenXCXiwen Chen
- Wanqing XiaoWXWanqing Xiao
- Yuyuan LiYLYuyuan Li
- 31 December 2006
- journal article
- review article
- Published by Elsevier in Surgical Oncology
- Vol. 15 (4) , 223-233
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Immunoprofiles of 11 Biomarkers Using Tissue Microarrays Identify Prognostic Subgroups in Colorectal CancerNeoplasia, 2005
- Aberration of FHIT Gene is Associated with Increased Tumor Proliferation and Decreased Apoptosis—Clinical Evidence in Lung and Head and Neck CarcinomasMolecular Medicine, 2001
- Frequent Altered Expression of Fragile Histidine Triad Protein in Human Colorectal AdenomasBiochemical and Biophysical Research Communications, 2000
- Clinicopathologic Features andFHITGene Expression in Sporadic Colorectal AdenocarcinomasScandinavian Journal of Gastroenterology, 2000
- Cell Death in DevelopmentCell, 1999
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Replacement of Fhit in cancer cells suppresses tumorigenicityProceedings of the National Academy of Sciences, 1997
- Alternative Splicing of the FHIT Gene in Colorectal CancersJapanese Journal of Cancer Research, 1997
- The FHIT Gene at 3p14.2 Is Abnormal in Lung CancerCell, 1996
- The FHIT Gene, Spanning the Chromosome 3p14.2 Fragile Site and Renal Carcinoma–Associated t(3;8) Breakpoint, Is Abnormal in Digestive Tract CancersCell, 1996